首站-论文投稿智能助手
典型文献
Regulatory effect of gut microbes on blood pressure
文献摘要:
Hypertension is an important global public health issue because of its high morbid-ity as well as the increased risk of other diseases. Recent studies have indicated that the development of hypertension is related to the dysbiosis of the gut microbiota in both animals and humans. In this review, we outline the interaction between gut microbiota and hypertension, including gut microbial changes in hypertension, the effect of microbial dysbiosis on blood pressure (BP), indicators of gut microbial dys-biosis in hypertension, and the microbial genera that affect BP at the taxonomic level. For example, increases in Lactobacillus , Roseburia , Coprococcus , Akkermansia , and Bifidobacterium are associated with reduced BP, while increases in Streptococcus , Blautia , and Prevotella are associated with elevated BP. Furthermore, we describe the potential mechanisms involved in the regulation between gut microbiota and hyper-tension. Finally, we summarize the commonly used treatments of hypertension that are based on gut microbes, including fecal microbiota transfer, probiotics and prebi-otics, antibiotics, and dietary supplements. This review aims to find novel potential genera for improving hypertension and give a direction for future studies on gut mi-crobiota in hypertension.
文献关键词:
作者姓名:
Dong Yan;Ye Sun;Xiaoyue Zhou;Wenhao Si;Jieyu Liu;Min Li;Minna Wu
作者机构:
Xinxiang Key Laboratory of Pathogenic Biology, Department of Pathogenic Biology, School of Basic Medical Sciences , Xinxiang Medical University , Xinxiang , China;Institute of Medical Laboratory Animal Science, Chinese Academy of Medical Sciences & Comparative Medical Center , Peking Union Medical College , Beijing , China;Department of Dermatology , the First Affiliated Hospital of Xinxiang Medical University , Xinxiang , China
引用格式:
[1]Dong Yan;Ye Sun;Xiaoyue Zhou;Wenhao Si;Jieyu Liu;Min Li;Minna Wu-.Regulatory effect of gut microbes on blood pressure)[J].动物模型与实验医学(英文),2022(06):513-531
A类:
prebi,crobiota
B类:
Regulatory,effect,gut,microbes,blood,pressure,Hypertension,important,global,public,health,issue,because,its,high,morbid,ity,well,increased,risk,other,diseases,Recent,studies,have,indicated,that,development,hypertension,related,dysbiosis,microbiota,both,animals,humans,In,this,review,outline,interaction,between,including,microbial,changes,indicators,genera,affect,taxonomic,level,For,example,increases,Lactobacillus,Roseburia,Coprococcus,Akkermansia,Bifidobacterium,are,associated,reduced,while,Streptococcus,Blautia,Prevotella,elevated,Furthermore,describe,potential,mechanisms,involved,regulation,Finally,summarize,commonly,used,treatments,fecal,transfer,probiotics,antibiotics,dietary,supplements,This,aims,find,novel,improving,give,direction,future
AB值:
0.532106
相似文献
A plant-based diet supplemented with Hermetia illucens alone or in combination with poultry by-product meal:one step closer to sustainable aquafeeds for European seabass
Ivana Lepen Pleić;Ivana Bušelić;Maria Messina;Jerko Hrabar;LukaŽuvić;Igor Talijančić;IvaŽužul;Tina Pavelin;Ivana Anđelić;Jelka Pleadin;Jasna Puizina;Leon Grubišić;Emilio Tibaldi;TanjaŠegvić-Bubić-Laboratory of Aquaculture,Institute of Oceanography and Fisheries,?etali?te I.Me?trovi?a 63,21000 Split,Croatia;Department of Agriculture,Food, Environmental and Animal Sciences,University of Udine,Udine,Italy;Department of Chemistry,Faculty of Science,University of Split,Ru?era Bo?kovi?a 33,21000 Split,Croatia;Croatian Veterinary Institute,Laboratory for Analytical Chemistry,Savska Cesta 143,10000,Zagreb,Croatia;Department of Biology,Faculty of Science,University of Split,Ru?era Bo?kovi?a 33,21000 Split,Croatia
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Liu Zuojing;Zhu Shiwei;He Meibo;Li Mo;Wei Hui;Zhang Lu;Sun Qinghua;Jia Qiong;Hu Nan;Fang Yuan;Song Lijin;Zhou Chen;Tao Heqing;Y Kao John;Zhu Huaiqiu;Owyang Chung;Duan Liping-Department of Gastroenterology, Peking University Third Hospital, Haidian District, Beijing 100191, China;Department of Ultrasound, Peking University Third Hospital, Haidian District, Beijing 100191, China;Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100187, China;Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, 6520 MSRB I, SPC 5682, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA
The gut microbial metabolite,3,4-dihydroxyphenylpropionic acid,alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice
Rui Li;Li Xie;Lei Li;Xiaojiao Chen;Tong Yao;Yuanxin Tian;Qingping Li;Kai Wang;Chenyang Huang;Cui Li;Yifan Li;Hongwei Zhou;Neil Kaplowitz;Yong Jiang;Peng Chen-Department of Pathophysiology,Guangdong Provincial Key Laboratory of Proteomics,School of Basic Medical Sciences,Southern Medical University,Guangzhou 510515,China;Microbiome Medicine Center,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Guangdong Provincial Key Laboratory of New Drug Screening,School of Pharmaceutical Science,Southern Medical University,Guangzhou 510515,China;Division of Hepatobiliopancreatic Surgery,Department of General Surgery,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;USC Research Center for Liver Disease,Department of Medicine,Keck School of Medicine of USC,Los Angeles,CA 90089,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。